San Diego, CA, United States of America

Srinivasan Babu


 

 

Average Co-Inventor Count = 6.9

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • San Diego, CA (US) (1996 - 2014)
  • South San Francisco, CA (US) (2013 - 2016)

Company Filing History:


Years Active: 1996-2016

Loading Chart...
Loading Chart...
Loading Chart...
18 patents (USPTO):Explore Patents

Title: Innovations of Srinivasan Babu

Introduction

Srinivasan Babu is a prominent inventor based in San Diego, California, known for his significant contributions to the field of pharmaceuticals. With a total of 18 patents to his name, he has made remarkable advancements in the development of compounds that have potential therapeutic applications, particularly in cancer treatment.

Latest Patents

Among his latest patents is a process for making hydroxylated cyclopentapyrimidine compounds and salts thereof. This invention provides new methods for making and purifying salts of these compounds, which serve as AKT inhibitors used in treating diseases such as cancer. Another notable patent involves the process for making thienopyrimidine compounds, specifically the dual mTOR/PI3K inhibitor GDC-0980. This compound has a complex structure and includes various stereoisomers, geometric isomers, tautomers, and pharmaceutically acceptable salts.

Career Highlights

Srinivasan Babu has worked with several esteemed companies in the pharmaceutical industry, including Agouron Pharmaceuticals, Inc. and Genentech, Inc. His work in these organizations has contributed to the development of innovative therapies that address critical health challenges.

Collaborations

Throughout his career, Srinivasan has collaborated with notable colleagues such as Travis Paul Remarchuk and Kim F Albizati. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

Srinivasan Babu's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator. His work continues to impact the development of important therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…